Mankind Pharma Launches Posaconazole Gastro Resistant Tablets

Mankind Pharma, the 4th largest pharmaceutical company in India, launches posaconazole gastro resistant tablets with the brand name Posaforce 100.Posaconazole gastro-resistant tablets is for treating mucormycosis patients. Posaconazole is found to be safer and effective drug of choice for the management of mucormycosis. Recently, posaconazole has also been approved by Drug Controller General of India (DCGI).In addition, guidelines from AIIMS and ICMR have also recommended use of posaconazole as an effective option for the management of mucormycosis. Posaconazole is US FDA approved antifungal drug with minimal potential for nephrotoxicity & excellent tolerability profile.The risk of contracting black fungus is extremely high in immunosuppressant cases or when the immunity is low because of the utilization of steroids, like in the treatment of Covid-19. Though steroids reduce inflammation in the lungs, they also reduce immunity and raise blood sugar levels. It is therefore vital for Covid-19 patients, especially with diabetes, to rigorously screen and control their sugar.On the launch, Mankind Pharma commented, As the cases of black fungus are increasing day by day, the product has been launched under posaconazole 100 tablets to fight against this infection. We at Mankind always strive to launch affordable medicines with an endeavour to achieve the best quality standards in the pharmaceutical industry.”Black fungus commonly occurs in soil, and airborne spores often produce infections. Life threatening conditions like severe Covid-19 infection; prolonged immune suppression or reduced immunity, uncontrolled diabetes mellitus or haematological malignancies and even open wounds contamination with Mucorales can lead to this rare, but if left untreated, severe infection.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!